As part of the Patient Protection and Affordable Act, the Sunshine Act requires medical device, pharmaceutical and similar companies to report any payment or other transfer of value to the Health and Human Services (HHS). While things aren’t yet set in stone, an article published on MedCityNews points to five steps companies can take to prepare for the Sunshine Act.